Work with SHV Energy to lower their CO2 emissions by 25% by 2025 - Submit your Porposal for a chance to get a fully paid pilot
Follow
More…

Covid-19 Innovation Challenges by Innoget

Hospital & Health Care • Innovation Intermediary • United Kingdom • 101 followers

Follow
More…

Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.

Latest Open Innovation Opportunities

  • Technology Offers (31)
Breathe free air of COVID-19 in indoor common areas

Breathe free air of COVID-19 in indoor common areas

Patents for licensing
  • +6 months
  • Hide post
New use for an existing drug as antiviral agent against SARS-CoV-2 to prevent or/and treat COVID-19

New use for an existing drug as antiviral agent against SARS-CoV-2 to prevent or/and treat COVID-19

Patents for licensing
  • +6 months
  • Hide post
SARS-CoV-2 Targeted Libraries for offer

SARS-CoV-2 Targeted Libraries for offer

Innovative Products and Technologies
  • +6 months
  • Hide post
Viral RNA-dependent RNA Polymerases

Viral RNA-dependent RNA Polymerases

Innovative Products and Technologies
  • +6 months
  • Hide post
SARS-CoV-2 RNA-dependent RNA Polymerase Targeted Library

SARS-CoV-2 RNA-dependent RNA Polymerase Targeted Library

Innovative Products and Technologies
  • +6 months
  • Hide post
SARS-CoV-2 Papain-like ProteaseTargeted Library

SARS-CoV-2 Papain-like ProteaseTargeted Library

Innovative Products and Technologies
  • +6 months
  • Hide post
SARS-CoV-2 NSP16 Targeted Library

SARS-CoV-2 NSP16 Targeted Library

Innovative Products and Technologies
  • +6 months
  • Hide post
SARS-CoV-2 Helicase Targeted Library

SARS-CoV-2 Helicase Targeted Library

Innovative Products and Technologies
  • +6 months
  • Hide post
A Novel Therapeutic Approach Targeting Coronavirus Replication-Essential RNAs by Oligonucleotides

A Novel Therapeutic Approach Targeting Coronavirus Replication-Essential RNAs by Oligonucleotides

Innovative Products and Technologies
  • +1 month
  • Hide post
The Use of Chip Scale Photonics for the Advanced, and Efficient Detection of Viruses

The Use of Chip Scale Photonics for the Advanced, and Efficient Detection of Viruses

Innovative Products and Technologies
  • +1 month
  • Hide post
Active Masks with Virus Neutralizing Properties

Active Masks with Virus Neutralizing Properties

Innovative Products and Technologies
  • +1 month
  • Hide post
Relieving Lung disease in COVID-19 Patients with Aerosols that Carry Viral Genes Inhibitors

Relieving Lung disease in COVID-19 Patients with Aerosols that Carry Viral Genes Inhibitors

Innovative Products and Technologies
  • +1 month
  • Hide post
5-MER Peptide to Ameliorate Coronavirus-Induced Inflammation of the Upper Respiratory Tract and Lungs

5-MER Peptide to Ameliorate Coronavirus-Induced Inflammation of the Upper Respiratory Tract and Lungs

Innovative Products and Technologies
  • +1 month
  • Hide post
High-Throughput Sequencing Methods to Test Samples

High-Throughput Sequencing Methods to Test Samples

Innovative Products and Technologies
  • +1 month
  • Hide post
Novel Activating Antibodies for Viral Treatment

Novel Activating Antibodies for Viral Treatment

Innovative Products and Technologies
  • +1 month
  • Hide post
Rapid Computational Screening of Natural Products for COVID-19 Anti-Viral Agents

Rapid Computational Screening of Natural Products for COVID-19 Anti-Viral Agents

Innovative Products and Technologies
  • +1 month
  • Hide post
Plant-based Diagnostic Kit to Detect Sick and Recovered SARS-CoV-2 Virus Patients

Plant-based Diagnostic Kit to Detect Sick and Recovered SARS-CoV-2 Virus Patients

Innovative Products and Technologies
  • +1 month
  • Hide post
Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19

Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19

Innovative Products and Technologies
  • +1 month
  • Hide post
Systematic Computational Drug Repositioning to Treat COVID-19

Systematic Computational Drug Repositioning to Treat COVID-19

Innovative Products and Technologies
  • +1 month
  • Hide post
Screening of Drugs to Inhibit Viral Infections

Screening of Drugs to Inhibit Viral Infections

Innovative Products and Technologies
  • +1 month
  • Hide post
A Unique Platform for Curing Coronavirus and Similar Lethal Diseases

A Unique Platform for Curing Coronavirus and Similar Lethal Diseases

Innovative Products and Technologies
  • +1 month
  • Hide post
Fooling the Virus: A Fusion Protein as Virus-Specific Therapeutic

Fooling the Virus: A Fusion Protein as Virus-Specific Therapeutic

Innovative Products and Technologies
  • +1 month
  • Hide post
Deciphering the Virus-Host Tango: Understanding network of interactions through evolution, structure, dynamics, and computational design

Deciphering the Virus-Host Tango: Understanding network of interactions through evolution, structure, dynamics, and computational design

Innovative Products and Technologies
  • +1 month
  • Hide post
Using Signature Genes to Detect Early-Stage Coronavirus and Predict Individual Outcomes

Using Signature Genes to Detect Early-Stage Coronavirus and Predict Individual Outcomes

Innovative Products and Technologies
  • +1 month
  • Hide post
Early warning system for detecting deterioration in post intensive care patients

Early warning system for detecting deterioration in post intensive care patients

Innovative Products and Technologies
  • +2 months
  • Hide post
S-PACES. People and vehicle monitoring IoT system to control confinement and healthcare measures during COVID-19

S-PACES. People and vehicle monitoring IoT system to control confinement and healthcare measures during COVID-19

Innovative Products and Technologies
  • +2 months
  • Hide post
Shimmer3 Bioimpedance Monitor - Monitoring HR, respiration rate and depth, and the increase in fluid in the lungs to triage and remotely monitor Covid-19 patients

Shimmer3 Bioimpedance Monitor - Monitoring HR, respiration rate and depth, and the increase in fluid in the lungs to triage and remotely monitor Covid-19 patients

Innovative Products and Technologies
  • +4 months
  • Hide post
COVID-19 Rapid Diagnostic Kit

COVID-19 Rapid Diagnostic Kit

Innovative Products and Technologies
  • +4 months
  • Hide post
Expertise in molecular biology either experimentally or computationally

Expertise in molecular biology either experimentally or computationally

Research Services and Capabilities
  • +4 months
  • Hide post
Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion Inhibitors

Inhibitors of Viral Infectivity: Amphipathic Nucleoside Derivatives as Fusion Inhibitors

Innovative Products and Technologies
  • +4 months
  • Hide post
Alphanosos rapid discovery technology against COVID 19

Alphanosos rapid discovery technology against COVID 19

Innovative Products and Technologies
  • +4 months
  • Hide post

Latest News

Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting

Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting

Published on 17 September, 2020

--- This article was originally published on the press room portal at lilly.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- - Primary endpoint of viral load change from baseline at day 11 was met for one of three doses; consistent effects of viral reduction seen at earlier time points - Rate of hospitalizations and ER visits was 1.7 percent (5/302) for LY-CoV555 ...
  • +6 months
  • Hide post
NIH researchers investigate virulence of SARS-CoV-2 virus

NIH researchers investigate virulence of SARS-CoV-2 virus

Published on 25 June, 2020

--- This article was originally published by Samantha Black, PhD, The Science Advisory Board staff writer on the digital media scienceboard.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- What makes the SARS-CoV-2 virus so virulent? Researchers from the U.S. National Institutes of Health (NIH) analyzed the genomics of the virus -- and compared it to other coron...
  • +1 month
  • Hide post
Sexton, BioSpherix collaborate to support cell & gene therapy needs

Sexton, BioSpherix collaborate to support cell & gene therapy needs

Published on 25 June, 2020

--- This article was originally published by The Science Advisory Board staff writers on the digital media scienceboard.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- Sexton Biotechnologies is partnering with BioSpherix Medical on the final steps of downstream bioprocessing, fill-finish. Sexton's off-the-shelf fill system, the Sexton Biotechnologies AF-500, ...
  • +1 month
  • Hide post
Ideaya and GSK partner on synthetic lethality programs

Ideaya and GSK partner on synthetic lethality programs

Published on 25 June, 2020

--- This article was originally published by The Science Advisory Board staff writers on the digital media scienceboard.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- Ideaya Biosciences and GlaxoSmithKline (GSK) have formed a strategic partnership in the emerging oncology field of synthetic lethality. Synthetic lethality occurs when the combination of two or...
  • +1 month
  • Hide post
Lilly begins phase III trial for COVID-19 therapy

Lilly begins phase III trial for COVID-19 therapy

Published on 19 June, 2020

--- This article was originally published by The Science Advisory Board staff writers on the digital media scienceboard.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- Eli Lilly has enrolled patients in a phase III study to evaluate the efficacy and safety of baricitinib in hospitalized adults with COVID-19. Baricitinib, marketed by the company as Olumiant, i...
  • +1 month
  • Hide post
Are interferons helpful or harmful during SARS-CoV-2 infection?

Are interferons helpful or harmful during SARS-CoV-2 infection?

Published on 19 June, 2020

--- This article was originally published by Samantha Black, PhD, The Science Advisory Board staff writer on the digital media scienceboard.net. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- The host immune system produces a variety of regulatory molecules, including interferons (IFNs), during a response to viral infection. Although previously considered beneficial,...
  • +1 month
  • Hide post
Scanning for answers to a pandemic

Scanning for answers to a pandemic

Published on 11 June, 2020

--- This article was originally published by Bill Gates on the digital media gatesnotes.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- A new surveillance program in Seattle is detecting cases of COVID-19 and helping guide public health responses. In any fight, it’s important to know your enemy. Unfortunately, in our battle against COVID-19, there’s a lot ...
  • +2 months
  • Hide post
Covid-19 Vaccine Generates Immune Response

Covid-19 Vaccine Generates Immune Response

Published on 11 June, 2020

--- This article was originally published by Alan on the digital media sciencebusiness.technewslist.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- First results from a clinical trial testing a vaccine to protect against Covid-19 infections show the vaccine produces an immune response in healthy participants. The trial, conducted by National Institute of Allergy ...
  • +2 months
  • Hide post
Announcing the COVID-19 Therapeutics Accelerator

Announcing the COVID-19 Therapeutics Accelerator

Published on 05 May, 2020

--- This article was originally published by Mark Suzman on the digital media gatesfoundation.org. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- The first time I ever wrote about global health was an article on the looming AIDS crisis in my native South Africa. My piece for the Johannesburg Star in 1991 reported dire predictions from experts about the potential of...
  • +3 months
  • Hide post
31 questions and answers about COVID-19: My thoughts on what to do now and other topics

31 questions and answers about COVID-19: My thoughts on what to do now and other topics

Published on 05 May, 2020

--- This article was originally published on March 19, 2020, by Bill Gates on the digital media gatesnotes.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- Yesterday I did a Reddit Ask Me Anything session on COVID-19. As usual, Redditors asked a lot of smart questions, and it was a great opportunity to have a fact-based discussion about this pandemic and what we...
  • +3 months
  • Hide post
COVID-19 clean-up will threaten EU digital and green goals

COVID-19 clean-up will threaten EU digital and green goals

Published on 05 May, 2020

--- This article was originally published on April 21, 2020, by Éanna Kelly on the digital media sciencebusiness.net. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- EU regional commissioner says Europe should not ‘destroy path we’re on’, but accepts demand for future funding will be dominated by post-pandemic rebuilding The EU commissioner who oversees reg...
  • +3 months
  • Hide post
Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19

Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19

Published on 05 May, 2020

--- This article was originally published on April 24, 2020 on the digital media who.int. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- Unprecedented gathering of heads of government, institutions and industry cements commitment to accelerate development and delivery for all populations Heads of state and global health leaders today made an unprecedented commitm...
  • +3 months
  • Hide post
Open Innovation and Multiparty Cooperation in Biotechnology and Pharmaceuticals: Alternative Measures in Times of Public Emergency

Open Innovation and Multiparty Cooperation in Biotechnology and Pharmaceuticals: Alternative Measures in Times of Public Emergency

Published on 04 May, 2020

--- This article was originally published on April 20, 2020, by HERDEM Attorneys at Law on the digital media lexology.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- The race for finding a cure for COVID-19 continues, as more research centers, private enterprises and universities around the globe concentrate on finding an antiviral or vaccine against the virus o...
  • +3 months
  • Hide post
Open innovation for Covid-19 crisis

Open innovation for Covid-19 crisis

Published on 04 May, 2020

--- This article was originally published on April 21, 2020, by Dr. Sheetal Menon on the digital media forbesindia.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- There is a need for collective and coordinated scientific undertakings on a global scale to rapidly expedite the development pipeline for drugs, vaccines, and diagnostics “We need our collective k...
  • +3 months
  • Hide post
Q BioMed Partner Mannin Research Developing Potential Treatment for Patients Infected with Coronavirus and Other Infectious Diseases

Q BioMed Partner Mannin Research Developing Potential Treatment for Patients Infected with Coronavirus and Other Infectious Diseases

Published on 16 April, 2020

--- This article was originally published on April 2, 2020, by Financial Buzz on the digital media financialbuzz.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- – Preclinical data show unique platform addresses vascular leakage, which may support the health of patients during coronavirus infection – Platform has been awarded grants from Canada and Europe...
  • +3 months
  • Hide post
From Vaccines to Testing, M2D2 is ‘Laser-Focused’ on the Coronavirus

From Vaccines to Testing, M2D2 is ‘Laser-Focused’ on the Coronavirus

Published on 16 April, 2020

--- This article was originally published on March 3, 2020, by Ed Brennen on University of Massachusetts Lowell's media portal. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- The announcement came in late June 2018, just as many people were turning their attention to Fourth of July cookouts and summer vacation plans. The federal agency tasked with solving critica...
  • +3 months
  • Hide post
Franz Fayot launches new aid linked to the development and production of products in the fight against Covid-19 for an envelope of 30 million euros

Franz Fayot launches new aid linked to the development and production of products in the fight against Covid-19 for an envelope of 30 million euros

Published on 15 April, 2020

--- This article was originally published on April 4, 2020, by The Ministry of the Economy on Meco.gouvernement.lu. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- As part of the economic stabilization program, the Government Council approved on April 8 on a proposal from the Minister of the Economy, Franz Fayot, an aid scheme to support both industrial research proj...
  • +3 months
  • Hide post
Pitt and UPMC roll out revolutionary way to test COVID-19 drugs

Pitt and UPMC roll out revolutionary way to test COVID-19 drugs

Published on 15 April, 2020

--- This article was originally published on April 9, 2020, 5 p.m by David Templeton  post-gazette.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- The overriding question in treating COVID-19 is whether such drugs as hydroxychloroquine or remdesivir — or multiple other drugs in the research pipeline — will make a difference? So University of Pittsb...
  • +3 months
  • Hide post

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

Published on 14 April, 2020

Issued: London, UK Companies to combine innovative technologies to develop an adjuvanted COVID-19 vaccine  Candidate vaccine expected to enter clinical trials in the second half of 2020 and, if successful, to be available in the second half of 2021 Sanofi and GSK today announce that they have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19, using innovative technology from both c...
  • +4 months
  • Hide post
Top Kitchenware Provider Lifetime Brands Talks Coronavirus And Open Innovation

Top Kitchenware Provider Lifetime Brands Talks Coronavirus And Open Innovation

Published on 12 April, 2020

--- This article was originally published on April 8, 2020, by Stephen Key on Forbes.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. ---- The cancelation and postponement of massive trade events like the international housewares show in Chicago and national hardware show in Las Vegas have resulted in many unanswered questions. At these one-of-a-kind annual meeting ...
  • +4 months
  • Hide post
Opinion: What is the role of innovation in COVID-19 response?

Opinion: What is the role of innovation in COVID-19 response?

Published on 12 April, 2020

------ This article was originally published on April 7, 2020, by  David Milestone  on Devex.com. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. ------ Crises generate a lot of energy that, if harnessed constructively, can be a great source of innovation. The COVID-19 response is producing inspiring innovative responses proving that, indeed, necessity is the mothe...
  • +4 months
  • Hide post
The Global Patent Race for a COVID-19 Vaccine

The Global Patent Race for a COVID-19 Vaccine

Published on 30 March, 2020

--- This article was originally published on March 24, 2020, by Rebeca Harasimowicz on the digital version of The National Law Review. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- As COVID-19 is causing chaos around the globe, the world’s largest economies are competing to be the first to find a cure to this new pandemic and taking measures to ensure that their...
  • +4 months
  • Hide post
Impact of the Corona crisis on startups & tech

Impact of the Corona crisis on startups & tech

Published on 26 March, 2020

OOn top of the human toll, the Corona crisis is an economic shock, unlike anything we’ve seen for a long time. Retail, mobility, and travel are especially hit. Other sectors are outperforming the market: food delivery, online groceries, telehealth, streaming, gaming and video conferencing. Zoom is now worth more than Uber. Should Lyft acquire its own food delivery business to weather the storm? Eventually, the recovery will come. Which sta...
  • +4 months
  • Hide post
Coronavirus will show VCs’ true colours

Coronavirus will show VCs’ true colours

Published on 25 March, 2020

--- This article was originally published on March 23, 2020, by Matt Clifford on Sifted.eu. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- Most of us in the startup community pride ourselves on knowing something about exponential growth. Even so, it’s been hard to take in how quickly coronavirus has changed the landscape in the last couple of weeks. Unfortunatel...
  • +4 months
  • Hide post
Innovation Imperatives from Covid-19

Innovation Imperatives from Covid-19

Published on 23 March, 2020

--- This article was originally published on March 18, 2020 by Henry Chesbrough, Contributor, at the online version of Forbes. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- With some delay, we humans are beginning to marshal our counter-attack against the coronavirus. Some nascent but promising developments across a number of areas are worth noting, for they sket...
  • +4 months
  • Hide post
The state of Open Innovation

The state of Open Innovation

Published on 23 March, 2020

--- This article was originally published on March 20, 2020 by Irving Wladawsky-Berger, at the online version of the Wall Street Journal. The article has been replicated on Innoget's Innovation Blog by Innoget's Editorial Staff for information purposes. --- Firms today recognize that there are more capabilities for innovation in the marketplace than what they can possibly create on their own. This open innovation model, the antithesis o...
  • +4 months
  • Hide post

About

Ahead of the current Coronavirus outbreak, Innoget is fully committed to contributing to mobilizing scientific and expert communities to find a real solution to the Covid-19 pandemic. Therefore, we're supporting worldwide calls and programs that could help in any aspects of the coronavirus crisis.

Is your organization promoting or looking for innovation or research initiatives to mitigate the Covid-19 outbreak? Email us at covid19@innoget.com to list them.

Channeled through Innoget's online open innovation network, initiatives in the health, virology, medicine, or novel technologies applied to human health, among others, are listed and disseminated to Innoget members -ranging from hospitals, research institutes, scientists, businesses, and public administrations- and innovation partners worldwide.

Contact person

Jordi Ràfols

CEO at Covid-19 Innovation Challenges by Innoget
https://www.innoget.com/group/covid-19-open-innovation-initiative
–
Hospital & Health Care
11-50 employees
Innovation Intermediary
2020
United Kingdom

About our Innovation Strategy

Innoget connects you and your team to 175,000+ decision-makers around the world, providing access to hundreds of innovation and research opportunities you will find nowhere else to solve actual challenges.

Being the partner of choice for thousands of organizations to generate new projects connecting with verified partners, Innoget has become the reference for effective online open innovation and technology transfer due to its leading platform Innoget.com.

Innoget.com provides integrated open innovation and technology transfer functionalities and services to both easily externalize and internationalize your scientific and technological offer, as well as to introduce you to hundreds of exclusive innovation needs published by our community of businesses.

Research areas (8)

Applications for HealthBiological SciencesMedicine, Human HealthClinical Research, TrialsMedical Research and 3 more

Latest Job Offers

Covid-19 Innovation Challenges by Innoget has't published any job offer yet

Latest Events

Covid-19 Innovation Challenges by Innoget hasn't published any Event yet

Related profiles

Innoget © 2022 Innoget